Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts

Authors:	Marta Baviera PharmD Stefano Genovese MD Vito Lepore MD Pierluca Colacioppo MSc Fabio Robusto MD Mauro Tettamanti MSc Antonio D'Ettorre MSc Fausto Avanzini MD Ida Fortino MSc Antonio Nicolucci MD Maria C Roncaglioni MSc Francesco Giorgino MD

Institution:	1. Laboratory of Cardiovascular Prevention, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy;2. Centro Cardiologico Monzino IRCCS, Milan, Italy;3. Coresearch Centre for Outcomes Research and Clinical Epidemiology, Pescara, Italy Laboratory of Cardiovascular Clinical Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy;4. Coresearch Centre for Outcomes Research and Clinical Epidemiology, Pescara, Italy;5. Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy;6. Regional Health Ministry, Milan, Italy;7. Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy

Abstract:

Keywords:	antihyperglycaemic drugs cardiovascular outcomes death glucagon-like peptide-1 receptor agonists sodium-glucose cotransporter-2 inhibitors